A simple blood test measuring neurofilament light chain, or NfL levels, may help predict the risk of developing brain diseases years before symptoms appear, according to neurologists. Elevated NfL levels indicate early nerve cell damage, offering a potential window for early intervention and monitoring for conditions like Alzheimer's, Parkinson's, and other neurodegenerative disorders.